PRESS RELEASE published on 07/09/2024 at 20:45, 1 year 6 months ago Inside Information / News release on accounts, results Acticor Biotech publishes its 2023 annual results, financial highlights, and financing outlook. Annual General Meeting scheduled for September 13, 2024 Annual General Meeting Financial Highlights 2023 Annual Results ACTICOR BIOTECH Financing Outlook
PRESS RELEASE published on 07/09/2024 at 20:45, 1 year 6 months ago Informations privilégiées / Communiqué sur comptes, résultats Acticor Biotech publie ses résultats financiers annuels pour 2023, avec une perte nette de 18,640 K€. La trésorerie s'élève à 3,9 M€. L'AG se tiendra le 13 septembre 2024 Résultats Financiers Assemblée Générale Trésorerie Perte Nette ACTICOR BIOTECH
BRIEF published on 05/15/2024 at 11:20, 1 year 8 months ago Résultats de l'étude ACTISAVE et perspectives futures d'ACTICOR BIOTECH ACTICOR BIOTECH Étude ACTISAVE Traitement AVC Glenzocimab ESOC 2024
BRIEF published on 05/15/2024 at 11:20, 1 year 8 months ago Results of the ACTISAVE study and future perspectives of ACTICOR BIOTECH Stroke Treatment ACTICOR BIOTECH Glenzocimab ESOC 2024 ACTISAVE Study
PRESS RELEASE published on 05/15/2024 at 11:15, 1 year 8 months ago Informations privilégiées / Autres communiqués ACTICOR BIOTECH présente les résultats de l'étude ACTISAVE sur le traitement de l'AVC ischémique lors de l'ESOC 2024. Perspectives prometteuses pour le glenzocimab malgré l'absence d'efficacité globale ACTICOR BIOTECH Glenzocimab ESOC 2024 AVC Ischémique ACTISAVE
PRESS RELEASE published on 05/15/2024 at 11:15, 1 year 8 months ago Inside Information / Other news releases ACTICOR BIOTECH presents main results of phase 2/3 ACTISAVE study on stroke treatment at ESOC 2024, targeting specific subgroups for potential benefits Stroke Treatment ACTICOR BIOTECH ESOC 2024 ACTISAVE Study Patient Subgroups
Published on 02/06/2026 at 03:50, 2 hours 33 minutes ago High Tide Resources annonce des placements privés sans courtier
Published on 02/06/2026 at 02:45, 3 hours 38 minutes ago High Tide Resources annonce des placements privés sans courtier
Published on 02/06/2026 at 00:57, 5 hours 26 minutes ago Noram Lithium Announces Closing of Fully Allocated Non-Brokered Financing
Published on 02/06/2026 at 00:00, 6 hours 23 minutes ago LIR Life Sciences Commences Project Phase 2 Peptide Design Program with Neuland Laboratories
Published on 02/05/2026 at 23:15, 7 hours 8 minutes ago Amarc Further Expands Its Toodoggone Technical Team
Published on 02/06/2026 at 06:05, 18 minutes ago Driven by Chairman Junhyuk Bang's Visionary Leadership, Coway Announces Financial Results for Q4 and FY2025
Published on 02/06/2026 at 05:50, 33 minutes ago CGTN: Xi Jinping's same-day calls with Putin and Trump underscore China's role in global stability
Published on 02/05/2026 at 19:27, 10 hours 55 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/05/2026 at 18:46, 11 hours 37 minutes ago EQS-Adhoc: Mayr-Melnhof Karton AG: Impairment requirements impact profit for the financial year 2025
Published on 02/05/2026 at 18:09, 12 hours 14 minutes ago Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/05/2026 at 19:15, 11 hours 8 minutes ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 02/05/2026 at 19:15, 11 hours 8 minutes ago ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES JANVIER 2026
Published on 02/05/2026 at 19:15, 11 hours 8 minutes ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
